Mission Bio Secures Equity Financing to Accelerate Single-Cell Tri-omics Platform Expansion

/in , , , /by

Investment to Drive Commercial Growth, Advance Single-Cell Tri-omics Capabilities and Clinical Applications Across Cancer Company Adds to Leadership Team, with Matthew H. Cato Joining as CCO SOUTH SAN FRANCISCO, Calif. – Mission Bio, a leader in single-cell multi-omics solutions for precision medicine, today announced the successful completion of equity financing led by Ally Bridge Group. […]

Read more →

Qlucore moves into new business areas and expands Board

/in , /by

Qlucore, a world leader in the development of bioinformatics software, is expanding into the area of precision medicine and precision diagnostics. In order to finance the expansion Qlucore has recently finalized a rights issue of 400k Euros and is pleased to announce two new members of the Board. Qlucore has created a software platform for […]

Read more →

H.E.L. Group appoints new CEO and secures £5.9 million GBP ($7.3 million USD) investment

/in /by

Louise Madden joins as CEO to drive Company’s growth strategy Investment by Connection Capital supports H.E.L. Group in servicing global demand for its products, including fast-growth markets in Asia Borehamwood, UK: H.E.L. Group Ltd, a global manufacturer of innovative laboratory tools for process optimization, safety and scale-up, today announced the appointment of Louise Madden as […]

Read more →